If you do have a UTI, you’ll need to take antibiotics to treat it ... or if you need help understanding your insurance coverage, help is available. The Gemtesa Simple Savings Program is available.

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...

Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions worldwide. However, the increasing resistance of bacteria to standard antibiotics has made ...

For millions of women, urinary tract infections (UTIs) are more than just a minor health nuisance – they are a recurring, disruptive burden. With rising antibiotic resistance making standard ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades. UTIs are infections in any part of the urinary system and ...

In children with febrile urinary tract infections (UTIs), an individualised antibiotic treatment regimen stopped 3 days after the achievement of adequate clinical improvement increased the risk ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant ...

A GSK pill that offers a lower potential for drug resistance is now FDA approved as a new treatment for a common type of urinary tract infection, the first new oral antibiotic for this indication ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ischemic stroke have been granted approval by the US Food and Drug ...